238 related articles for article (PubMed ID: 21454202)
21. Macular skin lesion and monoclonal lymphoplasmacytoid infiltrates. Occurrence in primary Waldenström's macroglobulinemia.
Mozzanica N; Finzi AF; Facchetti G; Villa ML
Arch Dermatol; 1984 Jun; 120(6):778-81. PubMed ID: 6426407
[TBL] [Abstract][Full Text] [Related]
22. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
Owen RG
Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
[TBL] [Abstract][Full Text] [Related]
23. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.
Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E
Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024
[TBL] [Abstract][Full Text] [Related]
24. CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL).
Kyrtsonis MC; Levidou G; Korkolopoulou P; Koulieris E; Bartzi V; Maltezas D; Pangalis GA; Kalpadakis C; Dimou M; Georgiou G; Vassilakopoulos TP; Angelopoulou MK; Salpeas V; Tsaftaridis P; Patsouris E; Panayiotidis P; Tzenou TK
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):99-102. PubMed ID: 21454203
[TBL] [Abstract][Full Text] [Related]
25. CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia.
Hunter ZR; Branagan AR; Manning R; Patterson CJ; Santos DD; Tournilhac O; Dorfman DM; Treon SP
Clin Lymphoma; 2005 Mar; 5(4):246-9. PubMed ID: 15794857
[TBL] [Abstract][Full Text] [Related]
26. Expression of CCL3 by neoplastic cells in patients with Waldenström's macroglobulinemia: an immunohistochemical study in bone marrow biopsies of 67 patients.
Terpos E; Tasidou A; Eleftherakis-Papaiakovou E; Christoulas D; Gavriatopoulou M; Gkotzamanidou M; Roussou M; Kastritis E; Papadaki T; Dimopoulos MA
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):115-7. PubMed ID: 21454208
[TBL] [Abstract][Full Text] [Related]
27. Bone-marrow plasma cell burden correlates with IgM paraprotein concentration in Waldenstrom macroglobulinaemia.
Pasricha SR; Juneja SK; Westerman DA; Came NA
J Clin Pathol; 2011 Jun; 64(6):520-3. PubMed ID: 21471142
[TBL] [Abstract][Full Text] [Related]
28. Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients.
Lin P; Bueso-Ramos C; Wilson CS; Mansoor A; Medeiros LJ
Am J Surg Pathol; 2003 Aug; 27(8):1104-13. PubMed ID: 12883242
[TBL] [Abstract][Full Text] [Related]
29. [The pathology and genetic background of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia].
Timár B
Magy Onkol; 2017 Mar; 61(1):6-11. PubMed ID: 28273183
[TBL] [Abstract][Full Text] [Related]
30. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma.
Jondeau K; Alterescu R; Franc B; Davi F; Massé JM; Boukour S; Le Parc JM; Cramer EM
Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885
[TBL] [Abstract][Full Text] [Related]
31. Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation.
Walsh SH; Laurell A; Sundström G; Roos G; Sundström C; Rosenquist R
Leuk Res; 2005 Jul; 29(7):729-34. PubMed ID: 15927667
[TBL] [Abstract][Full Text] [Related]
32. Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations.
Treon SP; Kelliher A; Keele B; Frankel S; Emmanouilides C; Kimby E; Schlossman R; Mitsiades N; Mitsiades C; Preffer F; Anderson KC
Semin Oncol; 2003 Apr; 30(2):248-52. PubMed ID: 12720146
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic algorithm of Waldenström's macroglobulinemia or lymphoplasmacytic lymphoma in Japan].
Sekiguchi N
Rinsho Ketsueki; 2021; 62(8):1139-1148. PubMed ID: 34497201
[TBL] [Abstract][Full Text] [Related]
34. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia associated with Hodgkin disease. A report of two cases.
Rosales CM; Lin P; Mansoor A; Bueso-Ramos C; Medeiros LJ
Am J Clin Pathol; 2001 Jul; 116(1):34-40. PubMed ID: 11447749
[TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry.
Ocio EM; del Carpio D; Caballero Á; Alonso J; Paiva B; Pesoa R; Villaescusa T; López-Anglada L; Vidriales B; García-Sanz R
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):93-5. PubMed ID: 21454201
[TBL] [Abstract][Full Text] [Related]
36. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.
Amaador K; Vos JMI; Pals ST; Kraan W; Dobber JA; Minnema MC; Koene HR; de Bruin PC; Zwinderman AH; Kersten MJ
Leuk Lymphoma; 2022 May; 63(5):1070-1079. PubMed ID: 34961399
[TBL] [Abstract][Full Text] [Related]
37. Residual monotypic plasma cells in patients with waldenstrom macroglobulinemia after therapy.
Barakat FH; Medeiros LJ; Wei EX; Konoplev S; Lin P; Jorgensen JL
Am J Clin Pathol; 2011 Mar; 135(3):365-73. PubMed ID: 21350089
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma.
Ocio EM; Hernandez JM; Mateo G; Sanchez ML; Gonzalez B; Vidriales B; Gutierrez NC; Orfao A; San Miguel JF
Clin Lymphoma; 2005 Mar; 5(4):241-5. PubMed ID: 15794856
[TBL] [Abstract][Full Text] [Related]
39. Coexistent adrenal diffuse large B cell lymphoma in a patient with Waldenström's macrogloblinemia/lymphoplasmacytic lymphoma.
Shingaki S; Yoshiki Y; Yamamoto K; Ota Y; Suzuki K
Ann Hematol; 2016 Oct; 95(10):1723-4. PubMed ID: 27365139
[No Abstract] [Full Text] [Related]
40. Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis.
Wang W; Lin P
Pathology; 2020 Jan; 52(1):6-14. PubMed ID: 31767130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]